ALPINE IMMUNE SCIENCES, INC. Contract Liability (Deferred Revenue)
ALPINE IMMUNE SCIENCES, INC. had Contract Liability (Deferred Revenue) of $10.23 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-05-09
- 2024-03-31: Contract with Customer, Liability, Current $10.23M.
- 2023-12-31: Contract with Customer, Liability, Current $16.29M.
- 2023-09-30: Contract with Customer, Liability, Current $30.09M.
- 2023-06-30: Contract with Customer, Liability, Current $37.25M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-03-31 | $10.23M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $16.29M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $30.09M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $37.25M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $40.40M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $35.57M 10-K · filed 2024-03-20 |
| 2022-09-30 | $46.21M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $42.92M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $51.76M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $51.77M 10-K · filed 2023-03-23 |
| 2021-09-30 | $48.10M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $48.96M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $34.52M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $31.63M 10-K · filed 2022-03-17 |
| 2020-09-30 | $28.50M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $23.69M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $344.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.44M 10-K · filed 2021-03-18 |
| 2019-09-30 | $2.07M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.11M 10-Q · filed 2019-08-13 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2017-12-31 | $277.00K 10-K · filed 2019-03-18 |